Not checked for notices yet.

Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression

Fang Liu, Aifang Xu, Yan Zhang and 5 more

International Journal of Infectious Diseases · 2020

doi:10.1016/j.ijid.2020.03.013

Cited by papers we hold 2

At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data · 2020
No notice
Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review · 2020
Corrected

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.